martes, 20 de febrero de 2018

Draft Recommendation Statement: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions - US Preventive Services Task Force

Draft Recommendation Statement: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions - US Preventive Services Task Force

U.S. Preventive Services Task Force banner

Draft Recommendation Statement and Draft Evidence Review:

Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults

The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults. The Task Force found that clinicians should refer patients who have obesity to multicomponent, intensive behavioral interventions. The draft recommendation statement and draft evidence review are available for review and public comment from February 20, 2018 to March 19, 2018 here.
The Draft Recommendation Statement and Draft Evidence Review Are Open to Public Comment
review and comment

COMMENTING DETAILS

Public Comment Period:

2/20/18 - 3/19/18

Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population
Recommendation
Grade
Adults
The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 kg/m² or higher to intensive, multicomponent behavioral interventions.
B

WHERE WE ARE IN THE PROCESS

Draft Research Plan
Final Research Plan
Draft Recommendation / Draft Evidence Review
Final Recommendation / Evidence Summary

No hay comentarios: